Extracellular matrix structure and tissue stiffness control postnatal lung development through the lipoprotein receptor-related protein 5/Tie2 signaling system

American Journal of Respiratory Cell and Molecular Biology

Volumn 49, Issue 6, 2013, Pages 1009-1018

  Mammoto, Tadanori ^a   Jiang, Elisabeth ^a   Jiang, Amanda ^a   Mammoto, Akiko ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alveolarization; Extracellular matrix; Lipoprotein receptor related protein 5; Lung injury; Tie2

Indexed keywords

3 AMINOPROPIONITRILE; ANGIOPOIETIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; PROTEIN LYSINE 6 OXIDASE; SMALL INTERFERING RNA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CROSS LINKING; EXTRACELLULAR MATRIX; HYPEROXIA; IN VITRO STUDY; LUNG DEVELOPMENT; LUNG INJURY; LUNG PARENCHYMA; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; POSTNATAL DEVELOPMENT; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; RIGIDITY; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; BIOMECHANICAL PHENOMENA; BRONCHOPULMONARY DYSPLASIA; DISEASE MODELS, ANIMAL; ELASTICITY; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; GENE EXPRESSION; HYPEROXIA; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; LUNG; LUNG INJURY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEIN-LYSINE 6-OXIDASE; RECEPTOR, TIE-2; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84890045883     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0147OC     Document Type: Article

References (50)

1. Burri PH. Structural aspects of postnatal lung development: alveolar formation and growth. Biol Neonate 2006;89:313-322.
2. Thebaud B. Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity. Neonatology 2007;91:291-297.
3. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 2000;279:L600-L607.
4. Abman SH. Bronchopulmonary dysplasia: a vascular hypothesis. Am J Respir Crit Care Med 2001;164:1755-1756.
5. Mammoto T, Chen J, Jiang E, Jiang A, Smith LE, Ingber DE, Mammoto A. Lrp5 regulates development of lung microvessels and alveoli through the angiopoietin-tie2 pathway. PLoS ONE 2012;7:e41596.
6. Hato T, Kimura Y, Morisada T, Koh GY, Miyata K, Tabata M, Kadomatsu T, Endo M, Urano T, Arai F, et al. Angiopoietins contribute to lung development by regulating pulmonary vascular network formation. Biochem Biophys Res Commun 2009;381:218-223.
7. Mammoto T, Ingber DE. Mechanical control of tissue and organ development. Development 2010;137:1407-1420.
8. Mammoto A, Mammoto T, Ingber DE. Mechanosensitive mechanisms in transcriptional regulation. J Cell Sci 2012;125:3061-3073.
9. Mammoto A, Connor KM, Mammoto T, Yung CW, Huh D, Aderman CM, Mostoslavsky G, Smith LE, Ingber DE. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 2009;457:1103-1108.
10. Moore KA, Polte T, Huang S, Shi B, Alsberg E, Sunday ME, Ingber DE. Control of basement membrane remodeling and epithelial branching morphogenesis in embryonic lung by Rho and cytoskeletal tension. Dev Dyn 2005;232:268-281.
11. Mammoto A, Mammoto T, Kanapathipillai M, Yung CW, Jiang E, Jiang A, Lofgren K, Gee E P S, Ingber DE. Control of lung vascular permeability and endotoxin-induced pulmonary edema by changes in extracellular matrix mechanics. Nature Comm 2013;4:1759-1768.
12. Bryan BA, D'Amore PA. What tangled webs they weave: Rho-GTPase control of angiogenesis. Cell Mol Life Sci 2007;64:2053-2065.
13. Kumarasamy A, Schmitt I, Nave AH, Reiss I, Van Der Horst I, Dony E, Roberts JD Jr, De Krijger RR, Tibboel D, Seeger W, et al. Lysyl oxidase activity is dysregulated during impaired alveolarization of mouse and human lungs. Am J Respir Crit Care Med 2009;180:1239-1252.
14. Thibeault DW, Mabry SM, Ekekezie II, Zhang X, Truog WE. Collagen scaffolding during development and its deformation with chronic lung disease. Pediatrics 2003;111:766-776.
15. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009;139:891-906.
16. Bland RD, Mokres LM, Ertsey R, Jacobson BE, Jiang S, Rabinovitch M, Xu L, Shinwell ES, Zhang F, Beasley MA. Mechanical ventilation with 40% oxygen reduces pulmonary expression of genes that regulate lung development and impairs alveolar septation in newborn mice. Am J Physiol Lung Cell Mol Physiol 2007;293:L1099-L1110.
17. Fornieri C, Baccarani-Contri M, Quaglino D Jr, Pasquali-Ronchetti I. Lysyl oxidase activity and elastin/glycosaminoglycan interactions in growing chick and rat aortas. J Cell Biol 1987;105:1463-1469.
18. Hilgendorff A, Parai K, Ertsey R, Jain N, Navarro EF, Peterson JL, Tamosiuniene R, Nicolls MR, Starcher BC, Rabinovitch M, et al. Inhibiting lung elastase activity enables lung growth in mechanically ventilated newborn mice. Am J Respir Crit Care Med 2011;184:537-546.
19. Bland RD, Ertsey R, Mokres LM, Xu L, Jacobson BE, Jiang S, Alvira CM, Rabinovitch M, Shinwell ES, Dixit A. Mechanical ventilation uncouples synthesis and assembly of elastin and increases apoptosis in lungs of newborn mice: prelude to defective alveolar septation during lung development? Am J Physiol Lung Cell Mol Physiol 2008;294:L3-L14.
20. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases. Dev Cell 2009;17:9-26.
21. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006;127:469-480.
22. Tchaparian EH, Uriu-Adams JY, Keen CL, Mitchell AE, Rucker RB. Lysyl oxidase and P-ATPase-7A expression during embryonic development in the rat. Arch Biochem Biophys 2000;379:71-77.
23. Chen CZ, Raghunath M. Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis state of the art. Fibrogenesis Tissue Repair 2009;2:7-16.
24. Kaarteenaho-Wiik R, Paakko P, Herva R, Risteli J, Soini Y. Type I and III collagen protein precursors and mRNA in the developing human lung. J Pathol 2004;203:567-574.
25. Pierce RA, Albertine KH, Starcher BC, Bohnsack JF, Carlton DP, Bland RD. Chronic lung injury in preterm lambs: disordered pulmonary elastin deposition. Am J Physiol 1997;272:L452-L460.
26. Mammoto T, Mammoto A, Torisawa YS, Tat T, Gibbs A, Derda R, Mannix R, De Bruijn M, Yung CW, Huh D, et al. Mechanochemical control of mesenchymal condensation and embryonic tooth organ formation. Dev Cell 2011;21:758-769.
27. Lu P, Takai K, Weaver VM, Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol 2011;3-26.
28. Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, Quaggin SE. Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 2011;121:2278-2289.
29. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996;87:1171-1180.
30. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55-60.
31. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, Yancopoulos GD. Increased vascularization in mice overexpressing angiopoietin-1. Science 1998;282:468-471.
32. Makinde TO, Agrawal DK. Increased expression of angiopoietins and Tie2 in the lungs of chronic asthmatic mice. Am J Respir Cell Mol Biol 2011;44:384-393.
33. Xu Y, Yu Q. Angiopoietin-1, unlike angiopoietin-2, is incorporated into the extracellular matrix via its linker peptide region. J Biol Chem 2001;276:34990-34998.
34. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, et al. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxiainduced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 2005;112:2477-2486.
35. Masckauchan TN, Agalliu D, Vorontchikhina M, Ahn A, Parmalee NL, Li CM, Khoo A, Tycko B, Brown AM, Kitajewski J. Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2. Mol Biol Cell 2006;17:5163-5172.
36. Gebb SA, Shannon JM. Tissue interactions mediate early events in pulmonary vasculogenesis. Dev Dyn 2000;217:159-169.
37. Alejandre-Alcazar MA, Michiels-Corsten M, Vicencio AG, Reiss I, Ryu J, De Krijger RR, Haddad GG, Tibboel D, Seeger W, Eickelberg O, et al. TGF-beta signaling is dynamically regulated during the alveolarization of rodent and human lungs. Dev Dyn 2008;237:259-269.
38. Akimov SS, Belkin AM. Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition. J Cell Sci 2001;114:2989-3000.
39. Wells RG, Discher DE. Matrix elasticity, cytoskeletal tension, and TGF-beta: the insoluble and soluble meet. Sci Signal 2008;1:pe13.
40. Merrilees MJ, Ching PS, Beaumont B, Hinek A, Wight TN, Black PN. Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease. Respir Res 2008;9:41.
41. Youssef J, Chen P, Shenoy VB, Morgan JR. Mechanotransduction is enhanced by the synergistic action of heterotypic cell interactions and TGF-beta1. FASEB J 2012;26:2522-2530.
42. Riley DJ, Kramer MJ, Kerr JS, Chae CU, Yu SY, Berg RA. Damage and repair of lung connective tissue in rats exposed to toxic levels of oxygen. Am Rev Respir Dis 1987;135:441-447.
43. Barry-Hamilton V, Spangler R, Marshall D, McCauley S, Rodriguez HM, Oyasu M, Mikels A, Vaysberg M, Ghermazien H, Wai C, et al. Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med 2010;16:1009-1017.
44. Rodriguez HM, Vaysberg M, Mikels A, McCauley S, Velayo AC, Garcia C, Smith V. Modulation of lysyl oxidase-like 2 enzymatic activity by an allosteric antibody inhibitor. J Biol Chem 2010;285:20964-20974.
45. Trackman PC, Kagan HM. Nonpeptidyl amine inhibitors are substrates of lysyl oxidase. J Biol Chem 1979;254:7831-7836.
46. Maki JM, Rasanen J, Tikkanen H, Sormunen R, Makikallio K, Kivirikko KI, Soininen R. Inactivation of the lysyl oxidase gene lox leads to aortic aneurysms, cardiovascular dysfunction, and perinatal death in mice. Circulation 2002;106:2503-2509.
47. Hornstra IK, Birge S, Starcher B, Bailey AJ, Mecham RP, Shapiro SD. Lysyl oxidase is required for vascular and diaphragmatic development in mice. J Biol Chem 2003;278:14387-14393.
48. Maki JM, Sormunen R, Lippo S, Kaarteenaho-Wiik R, Soininen R, Myllyharju J. Lysyl oxidase is essential for normal development and function of the respiratory system and for the integrity of elastic and collagen fibers in various tissues. Am J Pathol 2005;167:927-936.
49. Bruel A, Ortoft G, Oxlund H. Inhibition of cross-links in collagen is associated with reduced stiffness of the aorta in young rats. Atherosclerosis 1998;140:135-145.
50. Liu F, Mih JD, Shea BS, Kho AT, Sharif AS, Tager AM, Tschumperlin DJ. Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression. J Cell Biol 2010;190:693-706.